Israel’s Biocancell Therapeutics has reported a successful clinical trial on high-risk bladder cancer patients.  It will allow the company to proceed to a Phase III trial of its BC-819 product, which is administered together with BCG, the standard treatment.

http://www.globes.co.il/en/article-biocancell-share-jumps-on-positive-cancer-trial-results-1000974326